← Back to Home
Short Term·Markets Desk·Today
Short-Term Calls: RELIANCE, GRASIM and 47 More in Focus
Stockpro Online and 23 other SEBI-registered analysts issued 113 short term recommendations across 49 stocks over a two to four week horizon, with a broadly bullish bias.
By Markets Desk·113 Calls·109 Buy, 4 Sell
Stockpro Online and 23 other SEBI-registered analysts issued 113 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a broadly bullish bias — 109 buys against 4 sells — covering 49 stocks.
The 5 most-covered names of the session:
RELIANCE drew 22 calls — 21 buys and 1 sell — from Jefferies, JP Morgan, Nomura and 2 others, with entries between ₹1,164 and ₹1,782 and targets between ₹1,560 and ₹2,315.
GRASIM drew 10 calls — 10 buy calls — from Stockpro Online, Kunal Saraogi, with entries between ₹2,975 and ₹3,010 and targets between ₹3,020 and ₹3,075.
PIIND drew 6 calls — 6 buy calls — from Stockpro Online, with entries at ₹2,130 and targets between ₹2,140 and ₹2,170.
SUNPHARMA drew 6 calls — 6 buy calls — from Nomura, CITI, HSBC, with entries between ₹1,752 and ₹1,777 and targets between ₹2,100 and ₹2,400.
BANKBARODA drew 5 calls — 4 buys and 1 sell — from HSBC, JP Morgan, CITI, with entries between ₹238 and ₹238.6 and targets between ₹284 and ₹310.
The remaining 44 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — ZENTEC (₹1,745 → ₹2,000) via Stockpro Online; MAXHEALTH (₹26 → ₹38) via Rajesh Satpute; MORGAN (₹42.9 → ₹1,675) via JP Morgan; SAPPHIRE (₹204 → ₹220) via Kunal Saraogi; 770TGT41 (₹0 → ₹1,407) via Rajesh Satpute, Sachitanand Uttekar; AEGISLOG (₹1,156.9 → ₹1,250) via Prakash Gaba; ATHERENERG (₹1,755 → ₹1,825) via Manas Jaiswal; CIPLA (₹1,380 → ₹1,407) via Rakesh Bansal.
HDFCLIFE (₹529 → ₹540) via Kunal Saraogi; IOC (₹130 → ₹175) via Jefferies; THELEELA (₹653 → ₹725) via Icms1, Siddharth Ray Mangla; WELSPUNLIV (₹223 → ₹245) via Elitewealthltd; WEWORK (₹650 → ₹780) via Siddharth Ray Mangla; ZENSARTECH (₹550 → ₹580) via Elitewealthltd; AARTIDRUGS (₹458 → ₹516) via Rakesh Bansal; ARIES (₹425 → ₹1,710) via Jefferies.
BEL (₹369 → ₹525) via HSBC; BOSCHLTD (₹47,200 → ₹55,000) via Rakesh Bansal; CARERATING (₹1,659 → ₹1,800) via Lakshmishree; CDSL (₹1,263 → ₹1,315) via Jefferies; COFORGE (₹2,045 → ₹2,095) via Manas Jaiswal; DLF (₹694 → ₹722) via IIFLCapitalA; EIGHTY (₹1,782 → ₹2,315) via Morgan Stanley; FORCEMOT (₹17,840 → ₹18,000) via Prakash Gaba.
FORTIS (₹768 → ₹790) via Prakash Gaba; GESHIP (₹1,596 → ₹1,700) via Lakshmishree; HCLTECH (₹1,452 → ₹1,500) via Amit Seth; JINDALSTEL (₹1,076 → ₹1,100) via Prakash Gaba; JIOFIN (₹204.5 → ₹2,130) via Jefferies; NAVINFLUOR (₹8,680 → ₹10,540) via Jefferies; NITINSPIN (₹651 → ₹680) via Aastha Jain; NTPC (₹316 → ₹425) via Jefferies.
PERSISTENT (₹6,080 → ₹6,685) via Ashish Kyal; PILITA (₹70 → ₹75) via Aastha Jain; PPLPHARMA (₹240 → ₹250) via IIFLCapitalA; RAYMOND (₹1,118 → ₹1,300) via Lakshmishree; RELCHEMQ (₹1,164 → ₹1,840) via Goldman Sachs; SAMHI (₹156 → ₹166) via Jainamresearch; SBC (₹369 → ₹525) via HSBC; SHRIRAMFIN (₹846 → ₹880) via IIFLCapitalA.
SONACOMS (₹890 → ₹910) via Manas Jaiswal; TATAPOWER (₹353 → ₹370) via Manas Jaiswal; URJA (₹8.16 → ₹1,560) via Nomura.
Sell calls — PTL (₹38.49 → ₹590) via JP Morgan.
This roundup reproduces calls from 24 SEBI-registered Research Analysts: Stockpro Online (SEBI Reg. INH100006667); Jefferies (SEBI Reg. INH000000701); JP Morgan (SEBI Reg. INH000001873); Nomura (SEBI Reg. INH000001014); Kunal Saraogi (SEBI Reg. INH100001609); HSBC (SEBI Reg. INH000001287); Manas Jaiswal (SEBI Reg. INH100001625); Prakash Gaba (SEBI Reg. INH000001022); Elitewealthltd (SEBI Reg. INH100002300); Rajesh Satpute (SEBI Reg. INH000005494); Rakesh Bansal (SEBI Reg. INH100008984); IIFLCapitalA (SEBI Reg. INH000000248); Lakshmishree (SEBI Reg. INH000014395); Siddharth Ray Mangla (SEBI Reg. INH000024693); Aastha Jain (SEBI Reg. INH100002250); CITI (SEBI Reg. INH000000438); Morgan Stanley (SEBI Reg. INH000001105); Amit Seth (SEBI Reg. INH300009172); Ashish Kyal (SEBI Reg. INH000001097); Goldman Sachs (SEBI Reg. INH000001493); Icms1 (SEBI Reg. INH000002459); Jainamresearch (SEBI Reg. INH000006448); Sachitanand Uttekar (SEBI Reg. INH000004486); SARITA PANSARI (SEBI Reg. INH000016922).
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
SEBI-Registered Research Analysts
Stockpro Online · SEBI Reg. INH100006667Jefferies · SEBI Reg. INH000000701JP Morgan · SEBI Reg. INH000001873Nomura · SEBI Reg. INH000001014Kunal Saraogi · SEBI Reg. INH100001609HSBC · SEBI Reg. INH000001287Manas Jaiswal · SEBI Reg. INH100001625Prakash Gaba · SEBI Reg. INH000001022Elitewealthltd · SEBI Reg. INH100002300Rajesh Satpute · SEBI Reg. INH000005494Rakesh Bansal · SEBI Reg. INH100008984IIFLCapitalA · SEBI Reg. INH000000248Lakshmishree · SEBI Reg. INH000014395Siddharth Ray Mangla · SEBI Reg. INH000024693Aastha Jain · SEBI Reg. INH100002250CITI · SEBI Reg. INH000000438Morgan Stanley · SEBI Reg. INH000001105Amit Seth · SEBI Reg. INH300009172Ashish Kyal · SEBI Reg. INH000001097Goldman Sachs · SEBI Reg. INH000001493Icms1 · SEBI Reg. INH000002459Jainamresearch · SEBI Reg. INH000006448Sachitanand Uttekar · SEBI Reg. INH000004486SARITA PANSARI · SEBI Reg. INH000016922
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.